3.发表论文(具有代表性的5篇) (1)Yali Zhang#,*,Wenxin Zhang#, Jueqian Yan#, Yelin Tang, Wenjing Jia, Zhengwei Xu, Mingjiang Xu, Nipon Chattipakorn, Yi Wang, Jianpeng Feng, Zhiguo Liu*, Guang Liang*. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.Acta Pharmacologica Sinica, 2022, 43:76-85. (一区,IF= 6.15) (2)Yali Zhang#, Tingting Xu#, Zheer Pan#, Xiangting Ge, Chuchu Sun, Chun Lu, Hongjin Chen, Zhongxiang Xiao, Bing Zhang*, Yuanrong Dai*, Guang Liang*. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury.British Journal of Pharmacology, 2018, 175(5): 840-854. (一区,IF= 6.81) (3)Yali Zhang#, Zhiguo Liu#, Jianzhang Wu, Bin Bai, Hongjin Chen, Zhongxiang Xiao, Lingfeng Chen, Yunjie Zhao, Hazel Lum, Yi Wang, Hong Zhang*, Guang Liang*. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity.Eur. J Med. Chem,2018, 148: 291-305. (一区,IF= 4.816) (4)Yali Zhang#, Hongjin Chen#, Wenxin Zhang#, Yan Cai, Peiren Shan, Di Wu, Bing Zhang, Hui Liu, Zia Khan, Guang Liang*. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor4 signaling activation.BBA - Molecular Basis of Disease, 2020, 1866(5):165683. (一区,IF= 4.328) (5)Yali Zhang#, Beibei Wu#, Hailing Zhang, Xiangting Ge, Shilong Ying, Mengwei Hu, Weixin Li, Yi Huang, Li Wang, Chao Chen, Xiaoou Shan*, Guang Liang*. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.Journal of Cellular and Molecular Medicine, 2018, 22(2): 936-947. (二区,IF= 4.302)
|